Case number 1:23-cv-01219
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 30, 2025 | 29 | NOTICE of Withdrawal of Counsel by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals Inc. (Smith, Rodger) (Entered: 05/30/2025) (10) |
| Oct 16, 2024 | 28 | SO ORDERED Granting Stipulation and Order Regarding Consolidation and Schedule (D.I. 319 in 21-md-3017-RGA-LDH; D.I. 27 in 23-cv-1219-RGA; D.I. 166 in 21-cv-314-RGA-LDH). Signed by Judge Richard G. Andrews on 10/16/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 10/16/2024) (4) |
| Oct 15, 2024 | 27 | STIPULATION and Order Regarding Consolidation and Schedule (as to Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 10/15/2024) (4) |
| Oct 11, 2024 | 26 | ANSWER to 19 Answer to Complaint and Counterclaim of Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc., filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) Modified on 10/11/2024 (nms). (Entered: 10/11/2024) (13) |
| Oct 4, 2024 | 25 | NOTICE of Voluntary Dismissal by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. as to U.S. Patent 9,415,053 Counterclaims (Vrana, Robert) (Entered: 10/04/2024) (4) |
| Sep 27, 2024 | 24 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/27/2024 (nms). (Entered: 09/27/2024) (2) |
| Sep 12, 2024 | 23 | STIPULATION and Proposed Order to Extend Time to respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Complaint - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/12/2024 (nms). (Entered: 09/12/2024) (2) |
| Aug 27, 2024 | 22 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/27/2024 (nms). (Entered: 08/27/2024) (2) |
| Aug 9, 2024 | 21 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alkaloida Chemical Co. ZRT for Taro Pharmaceutical Industries Ltd.; Other Affiliate Sun Pharmaceutical Industries Ltd., Other Affiliate Taro Pharmaceuticals Industries Ltd. for Taro Pharmaceuticals U.S.A., Inc. filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) (Entered: 08/09/2024) (4) |
| Aug 9, 2024 | 20 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,415,053 . (Gaza, Anne) (Entered: 08/09/2024) (1) |
| Aug 9, 2024 | 19 | ANSWER to 1 Complaint, , COUNTERCLAIM against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1)(Gaza, Anne) (Entered: 08/09/2024) (0) |
| Jul 26, 2024 | 18 | STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) Modified on 7/26/2024 (nms). (Entered: 07/26/2024) (2) |
| Jul 1, 2024 | N/A | SO ORDERED, re 17 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 7/26/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 7/26/2024). Signed by Judge Richard G. Andrews on 7/1/2024. (nms) (Entered: 07/01/2024) (0) |
| Jun 28, 2024 | 17 | STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to July 26, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) (Entered: 06/28/2024) (2) |
| May 29, 2024 | N/A | SO ORDERED, re (D.I. 16 in 23-cv-1219-RGA; D.I. 271 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to June 28, 2024. Signed by Judge Richard G. Andrews on 5/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 05/29/2024) (0) |
| May 29, 2024 | 16 | STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 5/29/2024 (nms). (Entered: 05/29/2024) (2) |
| Apr 29, 2024 | N/A | SO ORDERED, re (D.I. 15 in 23-cv-1219-RGA; D.I. 261 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to May 29, 2024. Signed by Judge Richard G. Andrews on 4/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 04/29/2024) (0) |
| Apr 29, 2024 | 15 | STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to May 29, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 4/29/2024 (nms). (Entered: 04/29/2024) (2) |
| Mar 28, 2024 | 14 | STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) Modified on 3/28/2024 (nms). (Entered: 03/28/2024) (2) |
| Mar 28, 2024 | N/A | SO ORDERED, re 14 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 4/29/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 4/29/2024). Signed by Judge Richard G. Andrews on 3/28/2024. (lah) Modified on 3/28/2024 (nms). (Entered: 03/28/2024) (0) |
| Feb 27, 2024 | N/A | SO ORDERED, re 13 STIPULATION to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 3/28/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 3/28/2024). Signed by Judge Richard G. Andrews on 2/27/2024. (nms) (Entered: 02/27/2024) (0) |
| Feb 27, 2024 | 13 | STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to March 28, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 2/27/2024 (nms). (Entered: 02/27/2024) (2) |
| Feb 6, 2024 | N/A | SO ORDERED, re 12 STIPULATION to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 2/27/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 2/27/2024). Signed by Judge Richard G. Andrews on 2/6/2024. (nms) (Entered: 02/06/2024) (0) |
| Feb 6, 2024 | 12 | STIPULATION to Extend Time - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 2/6/2024 (nms). (Entered: 02/06/2024) (2) |
| Jan 18, 2024 | 11 | NOTICE of Appearance by Anne Shea Gaza on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. (Gaza, Anne) (Entered: 01/18/2024) (4) |
| Jan 18, 2024 | N/A | CORRECTING ENTRY: The notice filed at D.I. 11 on 1/18/2024, have been removed from the docket as the filing was incompletely formatted. This case is a member case to MDL 21-3017-RGA, and therefore all filings need to reflect the MDL case in the case caption. Counsel is to amend the notice and refile accordingly. (nms) (Entered: 01/18/2024) (0) |
| Jan 17, 2024 | N/A | SO ORDERED, re (D.I. 208 in 21-md-3017-RGA-LDH; D.I. 10 in 23-cv-1219-RGA) STIPULATION to Extend Time to answer, move, or otherwise respond to the Complaint to February 6, 2024. Signed by Judge Richard G. Andrews on 1/17/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 01/17/2024) (0) |
| Jan 16, 2024 | 10 | STIPULATION to Extend Time to answer, move, or otherwise respond to the Complaint to February 6, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 1/17/2024 (nms). (Entered: 01/16/2024) (2) |
| Nov 28, 2023 | 9 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Taro Pharmaceuticals U.S.A., Inc. waiver sent on 11/16/2023, answer due 1/16/2024. (Fahnestock, Derek) (Entered: 11/28/2023) (1) |
| Nov 28, 2023 | 8 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Taro Pharmaceutical Industries Ltd. waiver sent on 11/16/2023, answer due 1/16/2024. (Fahnestock, Derek) (Entered: 11/28/2023) (1) |
| Nov 1, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms) (Entered: 11/01/2023) (0) |
| Oct 26, 2023 | N/A | Remark: MDL Panel has been Notified. (apk) (Entered: 10/26/2023) (0) |
| Oct 26, 2023 | 7 | Summons Issued as to Taro Pharmaceutical Industries Ltd. on 10/26/2023; Taro Pharmaceuticals U.S.A., Inc. on 10/26/2023. (Attachments: # 1 Summons Issued)(apk) (Entered: 10/26/2023) (0) |
| Oct 26, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (apk) (Entered: 10/26/2023) (1) |
| Oct 26, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (apk) (Entered: 10/26/2023) (1) |
| Oct 26, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (apk) (Entered: 10/26/2023) (1) |
| Oct 26, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/12/2023. Date of Expiration of Patent: 1/31/39. (apk) (Entered: 10/26/2023) (1) |
| Oct 26, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 10/26/2023) (3) |
| Oct 26, 2023 | 1 | Complaint* (1) |
